Breadcrumbs Navigation

Home > News & Publications > News and Communications > News

Latest Health News from Duke Medicine News and Communications

 « Previous 10 Page of 27 Next 10 »

Duke Cancer Institute Joins National Endorsement of HPV Vaccination

In response to low national vaccination rates for the human papillomavirus (HPV), the Duke Cancer Institute has joined all 68 other top U.S. cancer centers in issuing a statement urging increased HPV vaccinations to prevent cancer.

Survival Period for Esophageal Cancer Is Tied to Race and Income

African-American patients with esophageal cancer survive fewer months after diagnosis than white patients, but only if they also have low incomes, according to a new study from Duke Health researchers.

Under the weather? A blood test can tell if antibiotics are needed

Researchers at Duke Health are fine-tuning a test that can determine whether a respiratory illness is caused by infection from a virus or bacteria so that antibiotics can be more precisely prescribed.

Immunity Genes Could Protect Some From E. Coli While Others Fall Ill

When a child comes home from preschool with a stomach bug that threatens to sideline the whole family for days, why do some members of the family get sick while others are unscathed? According to a Duke Health study published January 19 in the Journal of Infectious Diseases, a person’s resistance to certain germs, specifically E. coli bacteria, could come down to their very DNA.


News Tip: The best way to eat is to start meals and snacks from scratch, nutrition expert says

Elisabetta Politi, nutrition director at the Duke Diet & Fitness Center, comments on the 2015 Dietary Guidelines for Americans, released today by the U.S. Department of Agriculture and the U.S. Department of Health and Human Services. Currently, more than half the daily intake for the average American comes from mixed dishes, snacks, sweets and drinks. The new guidelines push for more plant-based foods and reducing reliance on quick and cheap processed snacks.

Early Trial Shows Injectable Agent Illuminates Cancer During Surgery

DURHAM, N.C. -- Doctors at Duke Medicine have tested a new injectable agent that causes cancer cells in a tumor to fluoresce, potentially increasing a surgeon’s ability to locate and remove all of a cancerous tumor on the first attempt. The imaging technology was developed through collaboration with scientists at Duke, the Massachusetts Institute of Technology (MIT) and Lumicell Inc.

Brain Regions of PTSD Patients Show Differences During Fear Responses

Regions of the brain function differently among people with post-traumatic stress disorder, causing them to generalize non-threatening events as if they were the original trauma, according to new research from Duke Medicine and the Durham VA Medical Center.

Older Breast Cancer Patients Defy Survival Models

Older women with early-stage, invasive breast cancer had better survival rates than what was estimated by a popular online tool for predicting survival, according to researchers at the Duke Cancer Institute.

Research yields potential treatment approach for glycogen storage disease

Researchers from the Duke-NUS Graduate Medical School Singapore (Duke-NUS) and Duke Medicine have identified a potential treatment strategy for an often-fatal inherited glycogen storage disease.

Study finds surprising links between bullies and eating disorders

Being bullied in childhood has been associated with increased risk for anxiety, depression and even eating disorders. But according to new research, it’s not only the victims who could be at risk psychologically, but also the bullies themselves.

 « Previous 10 Page of 27 Next 10 »